Regeneron Can't Ditch COVID-19 Tech Patent Suit
Regeneron Pharmaceuticals Inc. can't escape a suit claiming it used poached technology in its development and testing of COVID-19 vaccines and treatments, a New York federal judge ruled Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article